Traws Pharma Enters $50M Committed Equity Purchase Agreement With Roth Principal Investments; May Issue And Sell Up To 135,135,135 Shares Of Common Stock

Gap Stock Movers: SGRY Leads Gap-Ups and XP Leads Gap-Downs in Today's Session

Traws Pharma Enters Stock Purchase Agreement With Roth Principal Investments On Oct 23, 2026; May Sell Up To $50M In Common Stock To Roth Principal Investments

12 Health Care Stocks Moving In Monday's After-Market Session

Traws Pharma (NasdaqCM:TRAW) Stock Forecast & Analyst Predictions

Traws Pharma shares rise after Q2 loss comes in better than expected

Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights

TRAW Forecast — Price Target — Prediction for 2027

Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program

Traws Pharma Shares Slide After UK Regulator Postpones Influenza Study

$TRAW stock is down 24% today. Here's what we see in our data.

Traws Pharma Provides Regulatory Update on Influenza Program

Why Did TRAW Stock Slump 28% After Hours?

Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks

TRAW Stock Price and Chart — NASDAQ:TRAW